Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Launch One Acquisition | LPAAU | Nov 26, 2024 | 10.05 | 0.00 |
Launch Two Acquisition Units | LPBBU | Nov 26, 2024 | 10.00 | 0.00 |
Laureate Education | LAUR | Nov 26, 2024 | 19.13 | -2.94 |
LAVA Therapeutics | LVTX | Nov 26, 2024 | 1.55 | -3.73 |
Lavoro | LVRO | Nov 26, 2024 | 4.71 | -5.99 |
Lazard A | LAZ | Nov 26, 2024 | 58.16 | -2.51 |
Lazard Global Total Return and Income Fund | LGI | Nov 26, 2024 | 16.64 | -0.72 |
Lazydays | GORV | Nov 26, 2024 | 1.01 | +1.94 |
LCI Industries | LCII | Nov 26, 2024 | 123.18 | -2.78 |
LCNB | LCNB | Nov 26, 2024 | 17.27 | -2.04 |
Lead Real Estate ADR | LRE | Nov 26, 2024 | 2.33 | +4.68 |
Leafly | LFLY | Nov 26, 2024 | 1.49 | -3.87 |
Leap Therapeutics | LPTX | Nov 26, 2024 | 2.65 | +5.16 |
Lear | LEA | Nov 26, 2024 | 96.80 | -4.14 |
LeddarTech | LDTC | Nov 26, 2024 | 0.32 | -2.54 |
Lee Enterprises | LEE | Nov 26, 2024 | 16.25 | -1.04 |
Legacy Housing | LEGH | Nov 26, 2024 | 25.90 | -2.41 |
LegalZoom.com | LZ | Nov 26, 2024 | 7.94 | +0.38 |
Legato Merger III | LEGT | Nov 26, 2024 | 10.28 | -0.10 |
Legend Biotech ADR | LEGN | Nov 26, 2024 | 42.58 | -0.26 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Nov 26, 2024 | 41.16 | +0.34 |
Leggett & Platt | LEG | Nov 26, 2024 | 12.49 | -4.36 |
Leidos | LDOS | Nov 26, 2024 | 166.11 | +1.53 |
LeMaitre Vascular | LMAT | Nov 26, 2024 | 105.43 | -1.55 |
Lemonade | LMND | Nov 26, 2024 | 49.93 | -2.14 |
LendingClub | LC | Nov 26, 2024 | 16.34 | -1.45 |
LendingTree | TREE | Nov 26, 2024 | 43.70 | -4.92 |
Lendway | LDWY | Nov 26, 2024 | 4.64 | -7.20 |
Lennar A | LEN | Nov 26, 2024 | 173.40 | -2.94 |
Lennar B | LEN-B | Nov 26, 2024 | 163.62 | -2.76 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.